Dementia Big
Eli Lilly and Company today announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42.
http://ift.tt/1Tp22WK
Wednesday, January 27, 2016
Lilly, Roche Diagnostics partner to develop cerebrospinal fluid assay for amyloid-beta 1-42
Lilly, Roche Diagnostics partner to develop cerebrospinal fluid assay for amyloid-beta 1-42:
http://ift.tt/1Tp22WK
http://ift.tt/1Tp22WK
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment